| # | Drug | Count |
|---|---|---|
| 0 | ATORVASTATIN CALCIUM | 21 |
| 1 | CALCIUM | 21 |
| 2 | CLOZAPINE | 20 |
| 3 | PREGABALIN | 20 |
| 4 | TOPIRAMATE | 20 |
| 5 | DEXLANSOPRAZOLE | 19 |
| 6 | ERGOCALCIFEROL | 19 |
| 7 | OXYCODONE | 19 |
| 8 | QUETIAPINE | 19 |
| 9 | ONDANSETRON HYDROCHLORIDE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HALOPERIDOL DECANOATE | 15 | 0.0086 |
| 1 | ESTROGEN | 2 | 0.0007 |
| 2 | ERGOCALCIFEROL | 19 | 0.0006 |
| 3 | MIFEPRISTONE | 3 | 0.0006 |
| 4 | TALAZOPARIB | 1 | 0.0005 |
| 5 | DEXLANSOPRAZOLE | 19 | 0.0005 |
| 6 | DOSTARLIMAB | 1 | 0.0004 |
| 7 | TOPIRAMATE | 20 | 0.0004 |
| 8 | ZIPRASIDONE | 1 | 0.0003 |
| 9 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 22 |
| 1 | Proton Pump Inhibitor [EPC] | 22 |
| 2 | Calcium [EPC] | 21 |
| 3 | Opioid Agonist [EPC] | 21 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 21 |
| 5 | Platinum-based Drug [EPC] | 19 |
| 6 | Provitamin D2 Compound [EPC] | 19 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 18 |
| 8 | Corticosteroid [EPC] | 12 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 19 | 0.0006 |
| 1 | Progestin Antagonist [EPC] | 3 | 0.0006 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 3 | Calcium [EPC] | 21 | 0.0001 |
| 4 | Serotonin-3 Receptor Antagonist [EPC] | 18 | 0.0001 |
| 5 | Opioid Agonist [EPC] | 21 | 0.0001 |
| 6 | Platinum-based Drug [EPC] | 19 | 0.0001 |
| 7 | Purine Antimetabolite [EPC] | 6 | 0.0001 |
| 8 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |